Literature DB >> 34349001

G-Protein-Coupled Estrogen Receptor (GPER) in the Rostral Ventromedial Medulla Is Essential for Mobilizing Descending Inhibition of Itch.

Ting Gao1,2, Li Dong1,2, Jiahong Qian2,3, Xiaowei Ding1,2, Yi Zheng2, Meimei Wu1,2, Li Meng2, Yingfu Jiao2,3, Po Gao2,3, Ping Luo2, Guohua Zhang2, Changhao Wu4, Xueyin Shi5, Weifang Rong5,2.   

Abstract

Chronic itch is a troublesome condition and often difficult to cure. Emerging evidence suggests that the periaqueductal gray (PAG)-rostral ventromedial medulla (RVM) pathway may play an important role in the regulation of itch, but the cellular organization and molecular mechanisms remain incompletely understood. Here, we report that a group of RVM neurons distinctively express the G-protein-coupled estrogen receptor (GPER), which mediates descending inhibition of itch. We found that GPER+ neurons in the RVM were activated in chronic itch conditions in rats and mice. Selective ablation or chemogenetic suppression of RVM GPER+ neurons resulted in mechanical alloknesis and increased scratching in response to pruritogens, whereas chemogenetic activation of GPER+ neurons abrogated itch responses, indicating that GPER+ neurons are antipruritic. Moreover, GPER-deficient mice and rats of either sex exhibited hypersensitivity to mechanical and chemical itch, a phenotype reversible by the µ type opioid receptor (MOR) antagonism. Additionally, significant MOR phosphorylation in the RVM was detected in chronic itch models in wild-type but not in GPER-/- rats. Therefore, GPER not only identifies a population of medullary antipruritic neurons but may also determine the descending antipruritic tone through regulating µ opioid signaling.SIGNIFICANCE STATEMENT Therapeutic options for itch are limited because of an as yet incomplete understanding of the mechanisms of itch processing. Our data have provided novel insights into the cellular organization and molecular mechanisms of descending regulation of itch in normal and pathologic conditions. GPER+ neurons (largely GABAergic) in the RVM are antipruritic neurons under tonic opioidergic inhibition, activation of GPER promotes phosphorylation of MOR and disinhibition of the antipruritic GPER+ neurons from inhibitory opioidergic inputs, and failure to mobilize GPER+ neurons may result in the exacerbation of itch. Our data also illuminate on some of the outstanding questions in the field, such as the mechanisms underlying sex bias in itch, pain, and opioid analgesia and the paradoxical effects of morphine on pain and itch.
Copyright © 2021 the authors.

Entities:  

Keywords:  G-protein-coupled estrogen receptor; itch; rostral ventromedial medulla; µ type opioid receptor

Mesh:

Substances:

Year:  2021        PMID: 34349001      PMCID: PMC8445050          DOI: 10.1523/JNEUROSCI.2592-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Desensitization of mu-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the effector.

Authors:  Christophe Blanchet; Christian Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Why does morphine make you itch?

Authors:  Takashi Miyamoto; Ardem Patapoutian
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 3.  International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles.

Authors:  Peter C Mann; John Vahle; Charlotte M Keenan; Julia F Baker; Alys E Bradley; Dawn G Goodman; Takanori Harada; Ronald Herbert; Wolfgang Kaufmann; Rupert Kellner; Thomas Nolte; Susanne Rittinghausen; Takuji Tanaka
Journal:  Toxicol Pathol       Date:  2012-06       Impact factor: 1.902

Review 4.  Neurotransmitters in nociceptive modulatory circuits.

Authors:  H L Fields; M M Heinricher; P Mason
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

5.  Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine.

Authors:  Vittorio Verzillo; Priyanka A Madia; Nai-Jiang Liu; Sumita Chakrabarti; Alan R Gintzler
Journal:  J Neurochem       Date:  2014-06-11       Impact factor: 5.372

6.  The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat.

Authors:  H L Fields; J Bry; I Hentall; G Zorman
Journal:  J Neurosci       Date:  1983-12       Impact factor: 6.167

7.  Opioid receptor modulation of GABAergic and serotonergic spinally projecting neurons of the rostral ventromedial medulla in mice.

Authors:  Nigel P Pedersen; Christopher W Vaughan; MacDonald J Christie
Journal:  J Neurophysiol       Date:  2011-05-18       Impact factor: 2.714

8.  Yin-and-yang bifurcation of opioidergic circuits for descending analgesia at the midbrain of the mouse.

Authors:  Jong-Hyun Kim; Gireesh Gangadharan; Junweon Byun; Eui-Ju Choi; C Justin Lee; Hee-Sup Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-08       Impact factor: 11.205

9.  Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinociception.

Authors:  D R Loyd; M M Morgan; A Z Murphy
Journal:  Neuroscience       Date:  2007-05-31       Impact factor: 3.590

10.  TrkB-expressing paraventricular hypothalamic neurons suppress appetite through multiple neurocircuits.

Authors:  Juan Ji An; Clint E Kinney; Ji-Wei Tan; Guey-Ying Liao; Eric J Kremer; Baoji Xu
Journal:  Nat Commun       Date:  2020-04-07       Impact factor: 14.919

View more
  2 in total

Review 1.  A neuropeptide code for itch.

Authors:  Zhou-Feng Chen
Journal:  Nat Rev Neurosci       Date:  2021-10-18       Impact factor: 38.755

2.  Inhibition of itch by neurokinin 1 receptor (Tacr1) -expressing ON cells in the rostral ventromedial medulla in mice.

Authors:  Taylor Follansbee; Dan Domocos; Eileen Nguyen; Amanda Nguyen; Aristea Bountouvas; Lauren Velasquez; Mirela Iodi Carstens; Keiko Takanami; Sarah E Ross; Earl Carstens
Journal:  Elife       Date:  2022-08-16       Impact factor: 8.713

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.